StockWatch
·
Biotechnology: Pharmaceutical Preparations
RegulatoryJul 13, 2026, 08:02 AM

Apollomics Regains Compliance with Nasdaq Listing Requirements

AI Summary

Apollomics Inc. announced it has regained compliance with Nasdaq's Market Value of Listed Securities (MVLS) requirement, as set forth in Nasdaq Listing Rule 5550(b)(2). The company received written notice on July 8, 2026, confirming that the matter is now closed. Apollomics had previously been notified of non-compliance on June 18, 2026, but has since maintained an MVLS of $35 million or greater for 10 consecutive business days.

Key Highlights

  • Apollomics regained compliance with Nasdaq's MVLS requirement on July 8, 2026.
  • The company was previously notified of non-compliance on June 18, 2026.
  • Maintained a Market Value of Listed Securities (MVLS) of $35 million or greater.
  • Compliance was achieved for 10 consecutive business days, from June 23 to July 7, 2026.
  • The matter regarding Nasdaq Listing Rule 5550(b)(2) is now closed.